Form 4: Anixa Director Boosts Stake with 10,000 Share Purchase

Anixa Biosciences Director Arnold M. Baskies purchased 10,000 shares of common stock at $3.04 per share, increasing his direct beneficial ownership to 135,000 shares.

Summary

• Arnold M. Baskies, a Director of Anixa Biosciences Inc (ANIX), acquired 10,000 shares of common stock.
• The transaction occurred on January 28, 2026, at a price of $3.04 per share.
• Following this purchase, Mr. Baskies directly beneficially owns 135,000 shares of Anixa Biosciences common stock.
• The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, as insider buying typically reflects management's belief in the company's intrinsic value and future prospects.

Positives

• A Director's purchase of company stock signals confidence in the company's future prospects and valuation.
• The acquisition of 10,000 shares at $3.04 per share represents a direct investment by a key insider.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future financial performance or strategic direction.

Industry Context

StockSavvy.ai notes that insider buying, particularly by a director, is often interpreted by the market as a positive signal, suggesting that those closest to the company believe its shares are undervalued or expect positive developments. This contrasts with general market sentiment or competitor activity where insider selling might indicate concerns.

Related Party Transactions

• The transaction involves a director of Anixa Biosciences Inc purchasing company stock, which is a related party transaction.

Stakeholder Impact

• Shareholders may view this insider purchase as a positive sign, potentially increasing investor confidence in the company's stock.
• Employees might interpret this as a sign of stability and positive future outlook for the company.

Key Dates

Recommendation

A director's direct purchase of a significant number of shares, especially when executed under a Rule 10b5-1 plan, often signals strong conviction in the company's future performance and potential for stock appreciation. This insider confidence can be a compelling factor for investors to consider a 'buy' recommendation.

Keywords

Anixa Biosciences, ANIX, Insider Buying, Form 4, Director Purchase, Stock Acquisition, Arnold M. Baskies, Biotechnology